Skip to main content


Messenger RNA (mRNA) Therapeutics™ hold the potential to address a myriad of serious diseases that are not treatable through current approaches, and can be made and dosed with unprecedented precision and speed, vastly reducing the time and costs of traditional drug development.

Moderna is creating a unique ecosystem of in-house teams and partners to develop the broadest possible array of drugs imaginable and to develop them simultaneously. To accomplish this, we are forging strategic partnerships with pharmaceutical companiesgovernment organizations, foundations and research institutes with disease-specific expertise and resources to drive clinical programs forward, leveraging our mRNA Therapeutics™ platform, and to benefit patients as quickly as possible.